Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Carol Ann, Huff"'
Autor:
Ying S. Zou, Melanie Klausner, Jen Ghabrial, Victoria Stinnett, Patty Long, Laura Morsberger, Jaclyn B. Murry, Katie Beierl, Christopher D. Gocke, Rena R. Xian, Kevin H. Toomer, Jing Christine Ye, Robert Z. Orlowski, Carol Ann Huff, Syed Abbas Ali, Philip H. Imus, Christian B. Gocke, Guilin Tang
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/cab7ab5369954ec9946ccb2755f77a59
Autor:
Doris K. Hansen, Binod Dhakal, Mehdi Hamadani, David Dingli, Tania Jain, Carol Ann Huff, Murali Janakiram, Yi-Hsuan Liu, Kevin C. De Braganca, Nicole Lodowski, Jennifer Sander, Peter Okorozo, Lindsay McFarland, Matthew Perciavalle, Stephen Huo, Zaina P. Qureshi, Krina K. Patel
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionChimeric antigen receptor (CAR) T-cell therapy (CAR T therapy) is a treatment option for patients with relapsed or refractory multiple myeloma that has led to unprecedented treatment outcomes. Among CAR T therapies available, ciltacabtage
Externí odkaz:
https://doaj.org/article/7ded4f0c8f524a62a65d7cce93bbdc68
Autor:
Abhishek Gami, MD, John Woller, MD, Paul Scheel, MD, Syed Abbas Ali, MBBS, Carol Ann Huff, MD, Charles Steenbergen, Jr., MD, PhD, Marc Halushka, MD, PhD, Kavita Sharma, MD, Michael Polydefkis, MD, Joban Vaishnav, MD
Publikováno v:
JACC: Case Reports, Vol 29, Iss 7, Pp 102285- (2024)
Although most patients with cardiac amyloidosis are diagnosed with either light chain (AL) or transthyretin (ATTR) disease, coexisting amyloid subtypes can occur. We present three cases of coexisting AL and ATTR cardiac amyloidosis and demonstrate th
Externí odkaz:
https://doaj.org/article/85300b1c20cb4439a2a4ed56f26fc6c3
Autor:
Zhaohui Du, Niels Weinhold, Gregory Chi Song, Kristin A. Rand, David J. Van Den Berg, Amie E. Hwang, Xin Sheng, Victor Hom, Sikander Ailawadhi, Ajay K. Nooka, Seema Singhal, Karen Pawlish, Edward S. Peters, Cathryn Bock, Ann Mohrbacher, Alexander Stram, Sonja I. Berndt, William J. Blot, Graham Casey, Victoria L. Stevens, Rick Kittles, Phyllis J. Goodman, W. Ryan Diver, Anselm Hennis, Barbara Nemesure, Eric A. Klein, Benjamin A. Rybicki, Janet L. Stanford, John S. Witte, Lisa Signorello, Esther M. John, Leslie Bernstein, Antoinette M. Stroup, Owen W. Stephens, Maurizio Zangari, Frits Van Rhee, Andrew Olshan, Wei Zheng, Jennifer J. Hu, Regina Ziegler, Sarah J. Nyante, Sue Ann Ingles, Michael F. Press, John David Carpten, Stephen J. Chanock, Jayesh Mehta, Graham A. Colditz, Jeffrey Wolf, Thomas G. Martin, Michael Tomasson, Mark A. Fiala, Howard Terebelo, Nalini Janakiraman, Laurence Kolonel, Kenneth C. Anderson, Loic Le Marchand, Daniel Auclair, Brian C.-H. Chiu, Elad Ziv, Daniel Stram, Ravi Vij, Leon Bernal-Mizrachi, Gareth J. Morgan, Jeffrey A. Zonder, Carol Ann Huff, Sagar Lonial, Robert Z. Orlowski, David V. Conti, Christopher A. Haiman, Wendy Cozen
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 181-190 (2020)
Abstract: Persons of African ancestry (AA) have a twofold higher risk for multiple myeloma (MM) compared with persons of European ancestry (EA). Genome-wide association studies (GWASs) support a genetic contribution to MM etiology in individuals of E
Externí odkaz:
https://doaj.org/article/ba385add61f344c2bf8f3e2fb7c2bb2e
Autor:
Philip H. Imus, Hua-Ling Tsai, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Patrick Lowery, Richard F. Ambinder, Ivan M. Borrello, Lode J. Swinnen, Nina Wagner-Johnston, Christian B. Gocke, Syed Abbas Ali, F.Javier Bolaños-Meade, Ravi Varadhan, Richard J. Jones
Publikováno v:
Blood Advances, Vol 3, Iss 17, Pp 2608-2616 (2019)
Abstract: Hematologic malignancies in older people are unlikely to be cured with chemotherapy alone. Advances in allogeneic blood or marrow transplantation (alloBMT), especially nonmyeloablative (NMA) conditioning and the use of haploidentical donors
Externí odkaz:
https://doaj.org/article/197de5e065234acea249f8b75efa3cfa
Autor:
Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños-Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William H. Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik
Publikováno v:
Blood Advances, Vol 1, Iss 4, Pp 288-292 (2017)
Abstract: Allogeneic blood or marrow transplantation (BMT) candidates may lack HLA-matched, related haploidentical, and unrelated umbilical cord options. Barriers to partially HLA-mismatched, unrelated donor (mMUD) BMT include excess graft-versus-hos
Externí odkaz:
https://doaj.org/article/af2ec2c8d00b48949c2586a19a5e7f02
Autor:
Amy DeZern, Marianna L Zahurak, Heather J Symons, Kenneth R. Cooke, Carol Ann Huff, Tania Jain, Lode J Swinnen, Philip Hollingsworth Imus, Nina D. Wagner-Johnston, Richard F Ambinder, Mark J. Levis, Leo Luznik, Javier Bolaños-Meade, Ephraim J Fuchs, Richard J Jones, Robert A. Brodsky
Publikováno v:
Blood Journal.
Severe aplastic anemia (SAA) is a marrow failure disorder with high morbidity and mortality. It is treated with bone marrow transplantation (BMT) for those with fully matched donors or immunosuppressive therapy (IST) for those who lack such a donor,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e3d009596123a752e657d28ec5cc43
https://doi.org/10.1182/blood.2023020435
https://doi.org/10.1182/blood.2023020435
Autor:
William Matsui, Farhad Parhami, Carol Ann Huff, Ivan Borrello, Nilanjan Ghosh, Akil Merchant, Zeshaan Rasheed, Toshihiko Tanno, Qiuju Wang, Jasmin R. Agarwal
The Hedgehog (Hh) signaling pathway is aberrantly activated in a wide variety of human cancers, and recent clinical studies have demonstrated that pathway inhibitors are effective in advanced basal cell carcinoma (BCC). The majority of these agents h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55e657e1f4ccdc4b62605c35914fdf52
https://doi.org/10.1158/1535-7163.c.6536604.v1
https://doi.org/10.1158/1535-7163.c.6536604.v1
Autor:
William Matsui, Carol Ann Huff, Ivan Borrello, Syed A. Ali, Vesselin R. Penchev, Asma Begum, Qiuju Wang, Ross McMillan, Christian B. Gocke
Supplemental Figure 1. IQGAP1 levels correlate with disease progression and a poor prognosis;Supplemental Figure 2. IQGAP1 levels correlate with RAS pathway activation gene sets;Supplemental Figure 3. The impact of IQGAP1 WW peptide on cell cycle is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57010c34f4ea3dda9272810f037aa3e5
https://doi.org/10.1158/1535-7163.22505962
https://doi.org/10.1158/1535-7163.22505962
Autor:
William Matsui, Farhad Parhami, Carol Ann Huff, Ivan Borrello, Nilanjan Ghosh, Akil Merchant, Zeshaan Rasheed, Toshihiko Tanno, Qiuju Wang, Jasmin R. Agarwal
PDF - 177K, Figure S1. LXR expression in myeloma cell lines. Figure S2. Induction of LXR target genes by non-steroidal LXR agonists. Figure S3. Effects of LXR agonists on clonogenic myeloma growth. Figure S4. Impact of T0901317 on myeloma cell growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b48495a3fa945ae8d6c2bfcaa147b54
https://doi.org/10.1158/1535-7163.22500882.v1
https://doi.org/10.1158/1535-7163.22500882.v1